Small study questions ketamine's value as cancer pain drug

09/25/2012 | ABC (Australia) · Daily Telegraph (Australia), The

The anaesthetic drug ketamine's benefit in treating cancer pain may be outweighed by its side effects, according to Flinders University research in the Journal of Clinical Oncology. The small study of 185 patients found no better pain control than with a placebo as well as higher rates of toxicity and side effects.

View Full Article in:

ABC (Australia) · Daily Telegraph (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC